Fructose-1,6-bisphosphatase deficiency is a congenital error of metabolism, of autosomal recessive inheritance, caused by biallelic variants in the FBP1 gene. The lack of activity of this enzyme alters gluconeogenesis and causes episodic crises of ketotic hypoglycemia and lactic acidosis, especially during fasting, infections, or high fructose intake.
Fructose-1,6-bisphosphatase deficiency
The FBP1 gene encodes fructose-1,6-bisphosphatase 1, a key enzyme in hepatic and renal gluconeogenesis. This process allows glucose to be synthesized from lactate, glycerol, and amino acids, and is essential when glycogen stores are depleted, as occurs during fasting or intercurrent illnesses. The FBP1 enzyme catalyzes the conversion of fructose-1,6-bisphosphate to fructose-6-phosphate; therefore, pathogenic variants that reduce or abolish its activity block this metabolic pathway.
The main consequence is the inability to maintain blood glucose in situations of metabolic stress. Patients can accumulate gluconeogenic precursors, with increased lactate, ketones, and other metabolites, leading to lactic acidosis, ketosis, and hypoglycemia. The disease is inherited in an autosomal recessive manner and is rare; fewer than 200 cases have been reported in the literature, with a possibly higher frequency in populations with consanguinity. Between episodes, many individuals remain asymptomatic, and development is usually normal if crises are prevented and treated appropriately.
Symptoms
Symptoms usually begin in the neonatal period, infancy, or early childhood, although they may appear later. Attacks are triggered by fasting, fever, vomiting, infections, decreased oral intake, or high fructose consumption. They are characterized by ketotic hypoglycemia and lactic acidosis, with lethargy, irritability, hyperventilation or respiratory distress, apnea, vomiting, seizures, and, in severe cases, coma. Transient hepatomegaly may be observed during episodes. Between attacks, most affected individuals have no persistent symptoms.
Disease management
Prevention is based on avoiding prolonged fasting and ensuring a regular intake of carbohydrates, especially during childhood and in situations of illness. Frequent meals are recommended and, depending on age and specialist indication, raw cornstarch or slow-release glucose supplements. In episodes with fever, vomiting, or poor intake, early administration of oral or intravenous glucose may be necessary. Restriction of fructose, sucrose, sorbitol, and glycerol should be individualized, and having a metabolic emergency plan is essential.
Genes analyzed
Bibliography
Bhai P, Bijarnia-Mahay S, Puri RD, et al. Clinical and molecular characterization of Indian patients with fructose-1, 6-bisphosphatase deficiency: Identification of a frequent variant (E281K). Ann Hum Genet. 2018 Sep;82(5):309-317.
Bijarnia-Mahay S, Bhatia S, Arora V. Fructose-1,6-Bisphosphatase Deficiency. 2019 Dec 5. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Ni Q, Tang M, Chen X, et al. Fructose-1,6-bisphosphatase deficiency: estimation of prevalence in the Chinese population and analysis of genotype-phenotype association. Front Genet. 2024 Jul 5;15:1296797.
